Author

M. Benhamou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Klein Goldberg· 1 shared B. Liang· 1 shared C. Pellefigues· 1 shared C. Saji· 1 shared D. Simkin· 1 shared E. Sokol· 1 shared E. Yeini· 1 shared G. Gauthier· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Klein Goldberg

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Basophils drive the resolution and promote wound healing in adult and aged mice

J. Bex, V. Peter, C. Saji, L. Chapart, S. Jin, G. Gauthier, O. Thibaudeau, M. K. Thaminy, J. Tchen, Q. Simon, X. Dai, K. Miyake, H. Karasuyama, J. X. Jiang, K. Naidoo, , C. Pellefigues

This study shows basophils promote inflammation resolution and wound healing in both adult and aged mice by driving tissue remodeling and immunoregulatory functions.

bioRxiv · Jul 2, 2024Immunology

Genomic alterations drive brain metastases formation in colorectal cancer: The role of IRS2

I. Greenberg, E. Sokol, A. Klein Goldberg, D. Simkin, M. Benhamou, S. Bar-Shira, M. Raz, R. Grossman, E. Yeini, P. Ofek, B. Liang, R. Satchi-Fainaro, H. Reuveni, T. Rubinek, I. Wolf

This study identifies IRS2 amplification as a driver of brain metastases in colorectal cancer, showing its role in promoting tumor growth through β-catenin and OXPHOS pathways, and suggests NT219 as a potential therapeutic target.

bioRxiv · Jun 10, 2022 · PreprintCancer Biology